The contribution of inhibitory interneurons to circuit dysfunction in Fragile X Syndrome

Frontiers in Cellular Neuroscience

Volumn 8, Issue AUG, 2014, Pages

  Cea Del Rio, Christian A ^a   Huntsman, Molly M ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b Children's Hospital Colorado   (United States)

Author keywords

GABA; Inhibitory neurotransmission; Interneurons; Synaptic transmission; Synchronization

Indexed keywords

4 AMINOBUTYRIC ACID; N METHYL DEXTRO ASPARTIC ACID;

AUTISM; BEHAVIOR; COGNITIVE DEFECT; DEPOLARIZATION; ELECTROENCEPHALOGRAPHY PHASE SYNCHRONIZATION; FRAGILE X SYNDROME; HUMAN; INTERNEURON; NERVE CELL MEMBRANE POTENTIAL; NERVE CELL NETWORK; NEUROTRANSMISSION; NONHUMAN; PHENOTYPE; REVIEW; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

EID: 84929584074     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2014.00245     Document Type: Review

References (89)

1. Bacci, A., Huguenard, J. R., and Prince, D. A. (2004). Long-lasting self-inhibition of neocortical interneurons mediated by endocannabinoids. Nature 431, 312-316. doi: 10.1038/nature02913
2. Bear, M. F., Huber, K. M., and Warren, S. T. (2004). The mGluR theory of fragile X mental retardation. Trends Neurosci. 27, 370-377. doi: 10.1016/j.tins.2004.04.009
3. Beierlein, M., Gibson, J. R., and Connors, B. W. (2000). A network of electrically coupled interneurons drives synchronized inhibition in neocortex. Nat. Neurosci. 3, 904-910. doi: 10.1038/78809
4. Bell, K. A., Shim, H., Chen, C. K., and McQuiston, A. R. (2011). Nicotinic excitatory postsynaptic potentials in hippocampal CA1 interneurons are predominantly mediated by nicotinic receptors that contain alpha4 and beta2 subunits. Neuropharmacology 61, 1379-1388. doi: 10.1016/j.neuropharm.2011.08.024
5. Blatow, M., Rozov, A., Katona, I., Hormuzdi, S. G., Meyer, A. H., Whittington, M. A., et al. (2003). A novel network of multipolar bursting interneurons generates theta frequency oscillations in neocortex. Neuron 38, 805-817. doi: 10.1016/s0896-6273(03)00300-3
6. Bostrom, C. A., Majaess, N. M., Morch, K., White, E., Eadie, B. D., and Christie, B. R. (2013). Rescue of NMDAR-Dependent synaptic plasticity in Fmr1 knock-out mice. Cereb. Cortex doi: 10.1093/cercor/bht237. [Epub ahead of print].
7. Brown, V., Jin, P., Ceman, S., Darnell, J. C., O'Donnell, W. T., Tenenbaum, S. A., et al. (2001). Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell107, 477-487. doi: 10.1016/s0092-8674(01)00568-2
8. Buhl, E. H., Halasy, K., and Somogyi, P. (1994). Diverse sources of hippocampal unitary inhibitory postsynaptic potentials and the number of synaptic release sites. Nature 368, 823-828. doi: 10.1038/368823a0
9. Bureau, I., Shepherd, G. M., and Svoboda, K. (2008). Circuit and plasticity defects in the developing somatosensory cortex of FMR1 knock-out mice. J. Neurosci. 28, 5178-5188. doi: 10.1523/JNEUROSCI.1076-08.2008
10. Buzsáki, G., Horvath, Z., Urioste, R., Hetke, J., and Wise, K. (1992). High-frequency network oscillation in the hippocampus. Science 256, 1025-1027. doi: 10.1126/science.1589772
11. Cea-del Rio, C. A., Lawrence, J. J., Tricoire, L., Erdelyi, F., Szabo, G., and McBain, C. J. (2010). M3 muscarinic acetylcholine receptor expression confers differential cholinergic modulation to neurochemically distinct hippocampal basket cell subtypes. J. Neurosci. 30, 6011-6024. doi: 10.1523/JNEUROSCI.5040-09.2010
12. Chittajallu, R., Craig, M. T., McFarland, A., Yuan, X., Gerfen, S., Tricoire, L., et al. (2013). Dual origins of functionally distinct O-LM interneurons revealed by differential 5-HT(3A)R expression. Nat. Neurosci. 16, 1598-1607. doi: 10.1038/nn.3538
13. Cobb, S. R., Buhl, E. H., Halasy, K., Paulsen, O., and Somogyi, P. (1995). Synchronization of neuronal activity in hippocampus by individual GABAergic interneurons. Nature 378, 75-78. doi: 10.1038/378075a0
14. Coffee, B., Keith, K., Albizua, I., Malone, T., Mowrey, J., Sherman, S. L., et al. (2009). Incidence of fragile X syndrome by newborn screening for methylated FMR1 DNA. Am. J. Hum. Genet. 85, 503-514. doi: 10.1016/j.ajhg.2009.09.007
15. Conde, V., Palomar, F. J., Lama, M. J., Martinez, R., Carrillo, F., Pintado, E., et al. (2013). Abnormal GABA-mediated and cerebellar inhibition in women with the fragile X premutation. J. Neurophysiol. 109, 1315-1322. doi: 10.1152/jn.00730.2012
16. Cruz-Martín, A., Crespo, M., and Portera-Cailliau, C. (2010). Delayed stabilization of dendritic spines in fragile X mice. J. Neurosci. 30, 7793-7803. doi: 10.1523/JNEUROSCI.0577-10.2010
17. Deans, M. R., Gibson, J. R., Sellitto, C., Connors, B. W., and Paul, D. L. (2001). Synchronous activity of inhibitory networks in neocortex requires electrical synapses containing connexin36. Neuron 31, 477-485. doi: 10.1016/s0896-6273(01)00373-7
18. D'Hulst, C., De Geest, N., Reeve, S. P., Van Dam, D., De Deyn, P. P., Hassan, B. A., et al. (2006). Decreased expression of the GABAA receptor in fragile X syndrome. Brain Res. 1121, 238-245. doi: 10.1016/j.brainres.2006.08.115
19. Dölen, G., Osterweil, E., Rao, B. S., Smith, G. B., Auerbach, B. D., Chattarji, S., et al. (2007). Correction of fragile X syndrome in mice. Neuron 56, 955-962. doi: 10.1016/j.neuron.2007.12.001
20. Ebert, D. H., and Greenberg, M. E. (2013). Activity-dependent neuronal signalling and autism spectrum disorder. Nature 493, 327-337. doi: 10.1038/nature11860
21. Fanselow, E. E., and Connors, B. W. (2010). The roles of somatostatin-expressing (GIN) and fast-spiking inhibitory interneurons in UP-DOWN states of mouse neocortex. J. Neurophysiol. 104, 596-606. doi: 10.1152/jn.00206.2010
22. Fanselow, E. E., Richardson, K. A., and Connors, B. W. (2008). Selective, state-dependent activation of somatostatin-expressing inhibitory interneurons in mouse neocortex. J. Neurophysiol. 100, 2640-2652. doi: 10.1152/jn.90691.2008
23. Freund, T. F., and Katona, I. (2007). Perisomatic inhibition. Neuron 56, 33-42. doi: 10.1016/j.neuron.2007.09.012
24. Gantois, I., Vandesompele, J., Speleman, F., Reyniers, E., D'hooge, R., Severijnen, L. A., et al. (2006). Expression profiling suggests underexpression of the GABA(A) receptor subunit delta in the fragile X knockout mouse model. Neurobiol. Dis. 21, 346-357. doi: 10.1016/j.nbd.2005.07.017
25. García-Nonell, C., Ratera, E. R., Harris, S., Hessl, D., Ono, M. Y., Tartaglia, N., et al. (2008). Secondary medical diagnosis in fragile X syndrome with and without autism spectrum disorder. Am. J. Med. Genet. A 146A, 1911-1916. doi: 10.1002/ajmg.a.32290
26. Gibson, J. R., Bartley, A. F., Hays, S. A., and Huber, K. M. (2008). Imbalance of neocortical excitation and inhibition and altered UP states reflect network hyperexcitability in the mouse model of fragile X syndrome. J. Neurophysiol. 100, 2615-2626. doi: 10.1152/jn.90752.2008
27. Giráldez-Pérez, R. M., Avila, M. N., Feijóo-Cuaresma, M., Heredia, R., De Diego-Otero, Y., Real, M. A., et al. (2013). Males but not females show differences in calbindin immunoreactivity in the dorsal thalamus of the mouse model of fragile X syndrome. J. Comp. Neurol. 521, 894-911. doi: 10.1002/cne.23209
28. Glickfeld, L. L., and Scanziani, M. (2006). Distinct timing in the activity of cannabinoid-sensitive and cannabinoid-insensitive basket cells. Nat. Neurosci. 9, 807-815. doi: 10.1038/nn1688
29. Gonçalves, J. T., Anstey, J. E., Golshani, P., and Portera-Cailliau, C. (2013). Circuit level defects in the developing neocortex of fragile X mice. Nat. Neurosci. 16, 903-909. doi: 10.1038/nn.3415
30. Gulyás, A. I., Miles, R., Hájos, N., and Freund, T. F. (1993a). Precision and variability in postsynaptic target selection of inhibitory cells in the hippocampal CA3 region. Eur. J. Neurosci. 5, 1729-1751. doi: 10.1111/j.1460-9568.1993.tb00240.x
31. Gulyás, A. I., Miles, R., Sík, A., Tóth, K., Tamamaki, N., and Freund, T. F. (1993b). Hippocampal pyramidal cells excite inhibitory neurons through a single release site. Nature 366, 683-687. doi: 10.1038/366683a0
32. Gupta, A., Wang, Y., and Markram, H. (2000). Organizing principles for a diversity of GABAergic interneurons and synapses in the neocortex. Science 287, 273-278. doi: 10.1126/science.287.5451.273
33. Hagerman, R. J., Berry-Kravis, E., Kaufmann, W. E., Ono, M. Y., Tartaglia, N., Lachiewicz, A., et al. (2009). Advances in the treatment of fragile X syndrome. Pediatrics 123, 378-390. doi: 10.1542/peds.2008-0317
34. Hagerman, R. J., and Hagerman, P. J. (2002). The fragile X premutation: into the phenotypic fold. Curr. Opin. Genet. Dev. 12, 278-283. doi: 10.1016/s0959-437x(02)00299-x
35. Hagerman, P. J., and Stafstrom, C. E. (2009). Origins of Epilepsy in fragile X syndrome. Epilepsy Curr. 9, 108-112. doi: 10.1111/j.1535-7511.2009.01309.x
36. Hall, S. S., Lightbody, A. A., and Reiss, A. L. (2008). Compulsive, self-injurious and autistic behavior in children and adolescents with fragile X syndrome. Am. J. Ment. Retard. 113, 44-53. doi: 10.1352/0895-8017(2008)113[44:csaabi]2.0.co;2
37. Harlow, E. G., Till, S. M., Russell, T. A., Wijetunge, L. S., Kind, P., and Contractor, A. (2010). Critical period plasticity is disrupted in the barrel cortex of FMR1 knockout mice. Neuron 65, 385-398. doi: 10.1016/j.neuron.2010.01.024
38. Hays, S. A., Huber, K. M., and Gibson, J. R. (2011). Altered neocortical rhythmic activity states in Fmr1 KO mice are due to enhanced mGluR5 signaling and involve changes in excitatory circuitry. J. Neurosci. 31, 14223-14234. doi: 10.1523/JNEUROSCI.3157-11.2011
39. Heulens, I., D'Hulst, C., Van Dam, D., De Deyn, P. P., and Kooy, R. F. (2012). Pharmacological treatment of fragile X syndrome with GABAergic drugs in a knockout mouse model. Behav. Brain Res. 229, 244-249. doi: 10.1016/j.bbr.2012.01.031
40. Higashimori, H., Morel, L., Huth, J., Lindemann, L., Dulla, C., Taylor, A., et al. (2013). Astroglial FMRP-dependent translational down-regulation of mGluR5 underlies glutamate transporter GLT1 dysregulation in the fragile X mouse. Hum. Mol. Genet. 22, 2041-2054. doi: 10.1093/hmg/ddt055
41. Huber, K. M., Gallagher, S. M., Warren, S. T., and Bear, M. F. (2002). Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proc. Natl. Acad. Sci. U S A 99, 7746-7750. doi: 10.1073/pnas.122205699
42. Jung, K. M., Sepers, M., Henstridge, C. M., Lassalle, O., Neuhofer, D., Martin, H., et al. (2012). Uncoupling of the endocannabinoid signalling complex in a mouse model of fragile X syndrome. Nat. Commun. 3:1080. doi: 10.1038/ncomms2045
43. Kaufmann, W. E., Cortell, R., Kau, A. S., Bukelis, I., Tierney, E., Gray, R. M., et al. (2004). Autism spectrum disorder in fragile X syndrome: communication, social interaction and specific behaviors. Am. J. Med. Genet. A 129A, 225-234. doi: 10.1002/ajmg.a.30229
44. Kim, S. Y., Burris, J., Bassal, F., Koldewyn, K., Chattarji, S., Tassone, F., et al. (2014). Fear-specific amygdala function in children and adolescents on the fragile x spectrum: a dosage response of the FMR1 gene. Cereb. Cortex24, 600-613. doi: 10.1093/cercor/bhs341
45. Kim, H., Gibboni, R., Kirkhart, C., and Bao, S. (2013). Impaired critical period plasticity in primary auditory cortex of fragile X model mice. J. Neurosci. 33, 15686-15692. doi: 10.1523/JNEUROSCI.3246-12.2013
46. Klausberger, T., Magill, P. J., Márton, L. F., Roberts, J. D., Cobden, P. M., Buzsáki, G., et al. (2003). Brian-state and cell-type-specific firing of hippocampal interneurons in vivo. Nature 421, 844-848. doi: 10.1038/nature01374
47. Klausberger, T., and Somogyi, P. (2008). Neuronal diversity and temporal dynamics: the unity of hippocampal circuit operations. Science 321, 53-57. doi: 10.1126/science.1149381
48. Koekkoek, S. K., Yamaguchi, K., Milojkovic, B. A., Dortland, B. R., Ruigrok, T. J., Maex, R., et al. (2005). Deletion of FMR1 in Purkinje cells enhances parallel fiber LTD, enlarges spines and attenuates cerebellar eyelid conditioning in fragile X syndrome. Neuron 47, 339-352. doi: 10.1016/j.neuron.2005.07.005
49. Kratovac, S., and Corbin, J. G. (2013). Developmental changes in expression of inhibitory neuronal proteins in the fragile X syndrome mouse basolateral amygdala. Brain Res. 1537, 69-78. doi: 10.1016/j.brainres.2013.08.052
50. Lauterborn, J. C., Jafari, M., Babayan, A. H., and Gall, C. M. (2013). Environmental enrichment reveals effects of genotype on hippocampal spine morphologies in the mouse model of fragile X syndrome. Cereb. Cortex doi: 10.1093/cercor/bht249. [Epub ahead of print].
51. Lee, S. H., Foldy, C., and Soltesz, I. (2010). Distinct endocannabinoid control of GABA release at perisomatic and dendritic synapses in the hippocampus. J. Neurosci. 30, 7993-8000. doi: 10.1523/JNEUROSCI.6238-09.2010
52. Lindemann, L., Jaeschke, G., Michalon, A., Vieira, E., Honer, M., Spooren, W., et al. (2011). CTEP: a novel, potent, long-acting and orally bioavailable metabotropic glutamate receptor 5 inhibitor. J. Pharmacol. Exp. Ther. 339, 474-486. doi: 10.1124/jpet.111.185660
53. Liu, B., Li, L., Chen, J., Wang, Z., Li, Z., and Wan, Q. (2013). Regulation of GABAA receptors by fragile X mental retardation protein. Int. J. Physiol. Pathophysiol. Pharmacol. 5, 169-176.
54. Maccarrone, M., Rossi, S., Bari, M., De Chiara, V., Rapino, C., Bernardi, G., et al. (2010). Abnormal mGlu 5 receptor/endocannabinoid coupling in mice lacking FMRP and BC1 RNA. Neuropsychopharmacology 35, 1500-1509. doi: 10.1038/npp.2010.19
55. Marco, E. J., and Skuse, D. H. (2006). Autism-lessons from the X chromosome. Soc. Cogn. Affect. Neurosci. 1, 183-193. doi: 10.1093/scan/nsl028
56. Markram, H., Toledo-Rodriguez, M., Wang, Y., Gupta, A., Silberberg, G., and Wu, C. (2004). Interneurons of the neocortical inhibitory system. Nat. Rev. Neurosci. 5, 793-807. doi: 10.1038/nrn1519
57. Martin, B. S., Corbin, J. G., and Huntsman, M. M. (2014). Deficient tonic GABAergic conductance and synaptic balance in the fragile-X syndrome amygdala. J. Neurophysiol. doi: 10.1152/jn.00597.2013. [Epub ahead of print].
58. Meredith, R. M., Dawitz, J., and Kramvis, I. (2012). Sensitive time-windows for susceptibility in neurodevelopmental disorders. Trends Neurosci. 35, 335-344. doi: 10.1016/j.tins.2012.03.005
59. Merenstein, S. A., Sobesky, W. E., Taylor, A. K., Riddle, J. E., Tran, H. X., and Hagerman, R. J. (1996). Molecular-clinical correlations in males with an expanded FMR1 mutation. Am. J. Med. Genet. 64, 388-394. doi: 10.1002/(sici)1096-8628(19960809)64:2<388::aid-ajmg31>3.0.co;2-9
60. Michalon, A., Sidorov, M., Ballard, T. M., Ozmen, L., Spooren, W., Wettstein, J. G., et al. (2012). Chronic pharmacological mGlu5 inhibition corrects fragile X in adult mice. Neuron 74, 49-56. doi: 10.1016/j.neuron.2012.03.009
61. Miles, R., Tóth, K., Gulyás, A. I., Hájos, N., and Freund, T. F. (1996). Differences between somatic and dendritic inhibition in the hippocampus. Neuron 16, 815-823. doi: 10.1016/s0896-6273(00)80101-4
62. Musumeci, S. A., Hagerman, R. J., Ferri, R., Bosco, P., Dalla Bernardina, B., Tassinari, C. A., et al. (1999). Epilepsy and EEG findings in males with fragile X syndrome. Epilepsia 40, 1092-1099. doi: 10.1111/j.1528-1157.1999.tb00824.x
63. Olmos-Serrano, J. L., and Corbin, J. G. (2011). Amygdala regulation of fear and emotionality in fragile X syndrome. Dev. Neurosci. 33, 365-378. doi: 10.1159/000329424
64. Olmos-Serrano, J. L., Corbin, J. G., and Burns, M. P. (2011). The GABA(A) receptor agonist THIP ameliorates specific behavioral deficits in the mouse model of fragile X syndrome. Dev. Neurosci. 33, 395-403. doi: 10.1159/000332884
65. Olmos-Serrano, J. L., Paluszkiewicz, S. M., Martin, B. S., Kaufmann, W. E., Corbin, J. G., and Huntsman, M. M. (2010). Defective GABAergic neurotransmission and pharmacological rescue of neuronal hyperexcitability in the amygdala in a mouse model of fragile X syndrome. J. Neurosci. 30, 9929-9938. doi: 10.1523/JNEUROSCI.1714-10.2010
66. Paluszkiewicz, S., Martin, B., and Huntsman, M. (2011a). Fragile X syndrome: the GABAergic system and circuit dysfunction. Dev. Neurosci. 33, 349-364. doi: 10.1159/000329420
67. Paluszkiewicz, S. M., Olmos-Serrano, J. L., Corbin, J. G., and Huntsman, M. M. (2011b). Impaired inhibitory control of cortical synchronization in fragile X syndrome. J. Neurophysiol. 106, 2264-2272. doi: 10.1152/jn.00421.2011
68. Pan, F., Aldridge, G. M., Greenough, W. T., and Gan, W. B. (2010). Dendritic spine instability and insensitivity to modulation by sensory experience in a mouse model of fragile X syndrome. Proc. Natl. Acad. Sci. U S A 107, 17768-17773. doi: 10.1073/pnas.1012496107
69. Patel, A. B., Hays, S. A., Bureau, I., Huber, K. M., and Gibson, J. R. (2013). A target cell-specific role for presynaptic Fmr1 in regulating glutamate release onto neocortical fast-spiking inhibitory neurons. J. Neurosci. 33, 2593-2604. doi: 10.1523/JNEUROSCI.2447-12.2013
70. Penagarikano, O., Mulle, J. G., and Warren, S. T. (2007). The pathophysiology of fragile x syndrome. Annu. Rev. Genomics Hum. Genet. 8, 109-129. doi: 10.1146/annurev.genom.8.080706.092249
71. Porter, R. H., Jaeschke, G., Spooren, W., Ballard, T. M., Buttelmann, B., Kolczewski, S., et al. (2005). Fenobam: a clinically validated nonbenzodiazepine anxiolytic is a potent, selective and noncompetitive mGlu5 receptor antagonist with inverse agonist activity. J. Pharmacol. Exp. Ther. 315, 711-721. doi: 10.1124/jpet.105.089839
72. Real, M. A., Simon, M. P., Heredia, R., de Diego, Y., and Guirado, S. (2011). Phenotypic changes in calbindin D28K immunoreactivity in the hippocampus of Fmr1 knockout mice. J. Comp. Neurol. 519, 2622-2636. doi: 10.1002/cne.22643
73. Ronesi, J. A., Collins, K. A., Hays, S. A., Tsai, N. P., Guo, W., Birnbaum, S. G., et al. (2012). Disrupted homer scaffolds mediate abnormal mGluR5 function in a mouse model of fragile X syndrome. Nat. Neurosci. 15, 431-440. doi: 10.1038/nn.3033
74. Rotschafer, S., and Razak, K. (2013). Altered auditory processing in a mouse model of fragile X syndrome. Brain Res. 1506, 12-24. doi: 10.1016/j.brainres.2013.02.038
75. Selby, L., Zhang, C., and Sun, Q. Q. (2007). Major defects in neocortical GABAergic inhibitory circuits in mice lacking the fragile X mental retardation protein. Neurosci. Lett. 412, 227-232. doi: 10.1016/j.neulet.2006.11.062
76. Shaw, T. A., and Porter, M. A. (2013). Emotion recognition and visual-scan paths in fragile X syndrome. J. Autism. Dev. Disord. 43, 1119-1139. doi: 10.1007/s10803-012-1654-1
77. Szabadics, J., Lorincz, A., and Tamas, G. (2001). Beta and gamma frequency synchronization by dendritic gabaergic synapses and gap junctions in a network of cortical interneurons. J. Neurosci. 21, 5824-5831.
78. Till, S. M., Wijetunge, L. S., Seidel, V. G., Harlow, E., Wright, A. K., Bagni, C., et al. (2012). Altered maturation of the primary somatosensory cortex in a mouse model of fragile X syndrome. Hum. Mol. Genet. 21, 2143-2156. doi: 10.1093/hmg/dds030
79. Van der Molen, M. J., and Van der Molen, M. W. (2013). Reduced alpha and exaggerated theta power during the resting-state EEG in fragile X syndrome. Biol. Psychol. 92, 216-219. doi: 10.1016/j.biopsycho.2012.11.013
80. Van der Molen, M. J., Van der Molen, M. W., Ridderinkhof, K. R., Hamel, B. C., Curfs, L. M., and Ramakers, G. J. (2012). Auditory change detection in fragile X syndrome males: a brain potential study. Clin. Neurophysiol. 123, 1309-1318. doi: 10.1016/j.clinph.2011.11.039
81. Verkerk, A., Pieretti, M., Sutcliffe, J. S., Fu, Y. H., Kuhl, D. P., Pizzuti, A., et al. (1991). Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65, 905-914. doi: 10.1016/0092-8674(91)90397-h
82. Vislay, R. L., Martin, B. S., Olmos-Serrano, J. L., Kratovac, S., Nelson, D. L., Corbin, J. G., et al. (2013). Homeostatic responses fail to correct defective amygdala inhibitory circuit maturation in fragile X syndrome. J. Neurosci. 33, 7548-7558. doi: 10.1523/JNEUROSCI.2764-12.2013
83. Woodruff, A. R., and Sah, P. (2007a). Inhibition and synchronization of basal amygdala principal neuron spiking by parvalbumin-positive interneurons. J. Neurophysiol. 98, 2956-2961. doi: 10.1152/jn.00739.2007
84. Woodruff, A. R., and Sah, P. (2007b). Networks of parvalbumin-positive interneurons in the basolateral amygdala.J. Neurosci. 27, 553-563. doi: 10.1523/jneurosci.3686-06.2007
85. Xu, Z. H., Yang, Q., Ma, L., Liu, S. B., Chen, G. S., Wu, Y. M., et al. (2012b). Deficits in LTP induction by 5-HT2A receptor antagonist in a mouse model for fragile X syndrome. PLoS One 7:e48741. doi: 10.1371/journal.pone.0048741
86. Xu, Q., Zhu, Z., Xu, J., Gu, W., and Zhao, Z. (2012a). Depressed nNOS expression during spine transition in the developing hippocampus of FMR1 KO mice. Braz. J. Med. Biol. Res. 45, 1234-1239. doi: 10.1590/s0100-879x2012007500158
87. Yan, Q. J., Rammal, M., Tranfaglia, M., and Bauchwitz, R. P. (2005). Suppression of two major fragile X syndrome mouse model phenotypes by the mGluR5 antagonist MPEP. Neuropharmacology 49, 1053-1066. doi: 10.1016/j.neuropharm.2005.06.004
88. Zhang, L., and Alger, B. E. (2010). Enhanced endocannabinoid signaling elevates neuronal excitability in fragile X syndrome. J. Neurosci. 30, 5724-5729. doi: 10.1523/JNEUROSCI.0795-10.2010
89. Zoghbi, H. Y. (2003). Postnatal neurodevelopmental disorders: meeting at the synapse? Science 302, 826-830. doi: 10.1126/science.1089071